Cardiovascular
Aortic Valve Replacement
0
Pipeline Programs↗
4
Active Trials↗
0
Companies Involved↗
Aortic Valve Replacement is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
16
clinical trials
Completed8 · 50%
Recruiting2 · 13%
Unknown status2 · 13%
Suspended1 · 6%
Terminated1 · 6%
Not yet recruiting1 · 6%
Other1 · 6%
Clinical Trials
Trial Activity
16 trials
EMPagliflozin After Aortic Valve Replacement
Active, not recruiting·—·Phase 4·NCT06171802·205 enrolled
The Del Nido Versus Cold Blood Cardioplegia in Aortic Valve Replacement
Completed·—·N/A·NCT03818126·150 enrolled
Influence of Anesthetics on Clinical Outcome in Mitral and Aortic Valve Replacement in Adults
Completed·—·Phase 3·NCT05696509·75 enrolled
Buckberg vs Del Nido in Isolated Aortic Valve Replacement
Completed·FFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau·Phase 4·NCT04259515·286 enrolled
Erythropoietin + Iron Therapy for Anemic Patients Undergoing Aortic Valve Replacement
Completed·CCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec·Phase 3·NCT02390102·117 enrolled
Glucocorticoid Treatment in Transaortic Valve Replacement to Reduce the Incidence of Conduction Disturbances (GLUCO-TAVR).
Unknown status·—·Phase 4·NCT06076824·100 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)